Page last updated: 2024-10-30

meclofenamic acid and Experimental Mammary Neoplasms

meclofenamic acid has been researched along with Experimental Mammary Neoplasms in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, SZ1
Fulton, AM1

Other Studies

1 other study available for meclofenamic acid and Experimental Mammary Neoplasms

ArticleYear
Prostaglandin E2 receptor modulation affects tumor cell adhesion to laminin.
    Journal of cellular physiology, 1991, Volume: 149, Issue:2

    Topics: Amino Acid Sequence; Animals; Cell Adhesion; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-ch

1991